|
| Take
Less Medicine And Have Fewer Tension Headaches |
ST. LOUIS Tension headaches send most people to the
medicine cabinet in search of relief, but many of
the drugs they grab provide only a brief respite from
the pain. A new study by researchers at Saint Louis
University School of Medicine, however, suggests that
long-term relief is now possible with small doses
of botulinum toxin (botox).
The researchers found that small doses of botulinum
toxin Type A effectively relaxed the muscles involved
in triggering and/or perpetuating tension headache
pain. The study found that the injections reduced
the frequency of tension headaches for a majority
of patients for up to three months and slightly
reduced the intensity of the headaches.
Christina Burch, M.D., primary investigator and
assistant professor in the division of neurology
at Saint Louis University School of Medicine, presented
the findings at the Tenth Congress of the International
Headache Society in New York.
"Botulinum toxin Type A represents a new approach
to the management of frontal tension headaches,"
Dr. Burch said. "It allows therapy to be targeted
to specific problem muscles, which isn't possible
with existing medication, such as over-the-counter
aspirin or acetaminophen."
More than 78 percent of Americans suffer from chronic
or a bout of tension headaches in their lifetime.
Tension headaches are distinct from migraine headaches
or headaches triggered by lack of food, sleep, head
trauma or allergies/sinusitis. Tension headaches
are characterized by a sensation of painful tightness
around the head, which can be worse in some areas
than others. For people whose pain is predominately
in the front, furrowing the brow can become habitual
and worsen the symptoms. Forty-four percent of those
who suffer from tension headaches say the pain can
become strong enough to limit their ability to function.
To conduct the study on botox Type A, Dr. Burch
and her colleagues treated 41 patients who had at
least two frontal tension headaches a week. The
study was randomized so that some patients received
the botox injections and others received a placebo.
Treatment consisted of an office visit during which
patients received eight low dose injections of botox
Type A along the frontal is complex the area of
the forehead between the eyebrow and the hairline
in order to relax the muscles. The continuous contraction
of these muscles contributes to the pain associated
with a tension headache.
After treatment, patients in both the botox and
placebo groups reported fewer headaches than before
they began the study, but the frequency was even
lower for the botox patients. Furthermore, patients
in the botox group reported significantly lower
headache intensity ratings. In addition, patients
in the botox group reported that their headache
symptoms were easier to control. Dr. Burch and her
colleagues found that one botox Type A treatment
lasted three months or more.
Dr. Burch said people with tension headaches tend
to overmedicate by swallowing a pill whenever they
feel the pain coming on. Mild overdoses over time
can result in liver damage, stomach problems and
bleeding. "That's why it's good to have an
alternative," Dr. Burch said.
Botulinum toxin is a natural substance secreted
by the bacterium that causes botulism. Its beneficial
aspects were discovered by accident. Researchers
working on a vaccine for botulism injected the toxin
into muscle tissue and found that the toxin stayed
where it was placed. It did not travel into the
bloodstream or cause symptoms of botulism and it
appeared to relax muscles in the area injected.
Botox has been used successfully to help stroke
and cerebral palsy patients regain muscle control.
Physicians also are using botox to relax the vocal
cords of patients with speech impairments and to
ward off facial wrinkles. In Western Europe botox
is commonly used for treating tension headaches.
Dr. Burch said that one of the drawbacks of using
botox, however, is that because it is a natural
substance the human body eventually develops immunity
to it. Some patients may respond to botox for years
while it loses its effectiveness in others more
quickly.
"It's still very promising," said Dr.
Burch. "The patients in our study felt they
had control over something that had been out of
their control for years and given science, it won't
be long before we figure out a way around the immunity
issue."
|